Introduction {#sec1-1}
============

Population based cancer registry is currently unavailable in Nepal although there are twelve hospital based cancer registries (B P Koirala Memorial Cancer hospital, Bhaktapur Cancer Hospital, Bir hospital, TU Teaching Hospital, Kanti Children Hospital, BP Koirala Institute of Health Science and Manipal Teaching Hospital, Shree Birendra Hospital, Civil Service Hospital, Patan Hospital, Paropakar Maternity and Women Hospital and Nepalgunj Teaching Hospital) operating throughout this country \[ [@ref1] \]. The first hospital-based cancer registry was established in 2003 with the aid of the World Health Organization. Documents were previously issued which highlighted the problem of cancer cases in Nepal \[ [@ref2], [@ref3], [@ref4], [@ref5] \], however, owing to the lack of community based cancer registries, we have taken the population (denominator) from the census and cases from the hospital. This study primarily relies on the analysis of data from all the cancer registries in Nepal between 2010-2013 inclusive. In so doing, it has demonstrated the reality that hospital based study remains incomplete due to a lack of data because many people either remain incapable to visit hospitals or they are unaware of cancer. For any meaningful progress especially the reduction of cancers generally, it is imperative to secure the establishment of population based cancer registry in Nepal. The output of this study suggests there is an urgent necessity for cancer epidemiologists, statisticians as well as concerned stakeholders to invest in a preventative program to control and thereby prevent the increasing trend of cancers in Nepal.

Methodology {#sec1-2}
===========

Data of cancer cases was collected from all the hospital based cancer registries of Nepal between 1st January 2010 to 31st December 2013. All double/multiple entry cases were excluded by cross checking each patients name, sex, address and hospital registered number. We analyzed 13789 male cases and 16013 female cases which have known age. The collected data was entered in Excel Sheet with respect to age, sex, years and site. The population growth rate from 2001 to 2011 published in population monograph of Nepal volume 1 and the Census population of 2011 was used to estimate the 2010, 2012 and 2013 population of Nepal \[ [@ref6] \]. Cancer cases were categorized as per International Classification of Disease for Oncology (ICD-10) published by the International Agency for Research on Cancer/ World Health Organization (IARC/WHO). The crude incidence rate of cancer (per 100,000) in males and females of all sites are calculated. For statistical analysis, SPSS (version 23.0) and Microsoft Excel 2010 were used.

Results {#sec1-3}
=======

Lung cancer has the highest incidence (4.6) in males followed by stomach cancer (2.0) and larynx cancer (1.4) per 100,000 population from 2010 to 2013. Similarly, cervical cancer has the highest incidence (5.5) per 100,000 population in females followed by breast cancer (4.6) and lung cancer (3.0) over the same four-year period. The crude incidence of female cancer cases (29.2) per 100,000 population is higher than the crude incidence of male cancer cases (26.5) ([Table 2](#table002){ref-type="table"}).

Cancer both in males and females is increasing by calendar years([Table 1](#table001){ref-type="table"}) The incidence of three major cancers in males and females over the four-year period has been demonstrated in [figure 1](#fig001){ref-type="fig"} and [figure 2](#fig002){ref-type="fig"} respectively

Discussion: {#sec1-4}
===========

This study was undertaken in Nepal between 2010-2013 and presents the detail of cancer incidence by gender, sites and calendar years. Trends show that the cancer incidence is increasing every year especially for females. This is possibly due to increasing activities of screening programs in different areas of the country \[ [@ref7] \] and the support from the International Agency for Research on Cancer (IARC) for early detection and prevention of cervix and breast cancer \[ [@ref8] \]. Due to an increasing number of cancer diagnostic centers in Nepal, many people now also come forward to report the cancer cases which could be another possible cause for the growth of new cases of cancer in Nepal \[ [@ref9] \].

As a result of our studies we have found that bronchus and lung cancer is the most common cancer in males and the third common cancer in females. The crude incidence rate of lung cancer is 4.6 per 100,000 populations in Nepal while it was 4.45 in 2012 \[ [@ref5] \]. The following mitigating factors may have an effect on this trend: lower education, unmarried individuals and Rai/Limbu/Magar ethnicity \[ [@ref10] \], household air pollution and tobacco consumption \[ [@ref11], [@ref12] \], and not enough medical health education \[ [@ref13] \]. For young people in western Nepal; smoking was a serious issue \[ [@ref14] \] and the risk factor leading to lung cancer \[ [@ref15] \]. The crude incidence rate of lung cancer is 3.0 per 100,000 populations in Nepal while it was 2.85 in previous years \[ [@ref5] \].

Cervical uteri cancer is the most common type of cancer in females. The crude incidence rate of cervical uteri is 5.5 per 100,000 population in Nepal while it was 5.35 in 2012 \[ [@ref5] \]. Women do not have enough information regarding the human papillomavirus (HPV), cervical cancer and HPV vaccine \[ [@ref16] \], or concept of pap smear test \[ [@ref17] \]. Using the HPV16/18 vaccines, almost 80% of cervical cancer in Nepal could be prevented \[ [@ref18] \].

Breast cancer is the second most common cancer in females with more than a quarter occurring in young females. The more aggressive biological features of tumors were found in this at-risk group therefore we conclude that breast cancer prevention programs are essential to reduce this trend \[ [@ref19] \]. The crude incidence rate of breast cancer is (4.6) per 100,000 populations in Nepal while it was 4.59 in 2012 \[ [@ref5] \].

Ovarian cancer is the fourth most common cancer in females over this four-year period. The incidence of ovarian cancer is (1.9) per 100,000 populations while it was (1.70) in 2012 ( \[ [@ref5] \].

Stomach cancer is the second most common cancer in males while it is the fifth common cancer in females for the same period. The crude incidence rate of stomach cancer in males is (2.0) per 100,000 populations in Nepal, while it was 1.84 in 2012 \[ [@ref5] \].

Analyzing the data from B P Koirala Memorial Cancer Hospital, out of 7212 (7.3%) presented as stomach cancer \[ [@ref3] \]. Similarly, another study in 2005 reported out of 4397 cases (7.5%) represented male stomach cancer rates while the corresponding percentage of females was (4.1%) \[ [@ref2] \]. In female, the incidence of stomach cancer was 1.2 per 100,000 population over the four year period while it was 1.06 in 2012 \[ [@ref5] \]. Stomach cancer incidence rated men almost two times higher as compared to women although there is a worldwide variation in trend \[ [@ref15] \].

Larynx cancer was the third most common cancer in males over the four-year period 2010 - 2013. The crude incidence rate of larynx cancer is (1.4) per 100,000 populations, while it was 1.0 in 2012 \[ [@ref5] \]. Out of 7212 cases in 2012 (5.2%) were the larynx cases \[ [@ref3] \]. Similarly, another study in 2005 reported out of 4397 cases, 3.7% presented as larynx cancer in males while the corresponding percentage in females was 1.3% cases \[ [@ref2] \].

Ovarian cancer (1.9 per 100,000 populations) is the fourth most common cancer in females while gall bladder (1.1 per 100,000 population) represents the fifth most common cancer in Nepal throughout the four-year period 2010 - 2013. Bladder cancer (1.3 per 100,000 population) is the fourth most common cancer in males while cancer of other and unspecified parts of mouth is the fifth most common cancer in Nepal for the same period.

In conclusion cancer incidence in Nepal is growing at a higher rate for both males and females. The most common cancers in males are bronchus and lung, stomach and larynx while in females cervical uteri, breast, bronchus and lung are the most common cancers.

What is already known on this topic: {#sec4-1}
------------------------------------

A couple of studies had been conducted to demonstrate the incidence of cancer in Nepal which had only focused the single calendar year.

What this study adds: {#sec4-2}
---------------------

This study is different from the previous studies in Nepal because it has clearly presented the cancer incidence of all sites over the recent four years. Furthermore, this study also performed the incidence of three major cancers in males and females from 2010 to 2013.
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![Figure 1: Crude incidence of three major cancers in males from 2010 to 2013.](nje-07-659-g001){#fig001}

![Figure 2: Crude incidence of three major cancers in females from 2010 to 2013](nje-07-659-g002){#fig002}

###### 

Table 1. Summary of cancer cases and incidence per 1, 00,000 people in Nepal from 2010 to 2013.

  ----------- ---------------------- ------------------------ -------------------------------------- ----------------------------------------
  **Years**   **Total male cases**   **Total Female cases**   **Male crude incidence per 100,000**   **Female crude incidence per 100,000**
  **2010**    3192                   3581                     24.8                                   27.8
  **2011**    3295                   3793                     26.6                                   27.5
  **2012**    3291                   3921                     25.2                                   28
  **2013**    4011                   4718                     30.4                                   33.3
  ----------- ---------------------- ------------------------ -------------------------------------- ----------------------------------------

###### 

Table 2. Distribution of cancer site in males and females in Nepal from 2010 to 2013.

  -------- ------- --------- --------------- ------- --------- --------------- ------------------------------------------------------------
           Male    Female                                                      
                             (Per 100,000)                     (Per 100,000)   Site
  ICD-10   cases   Fre (%)   Crude rate      cases   Fre (%)   Crude rate      
  C00      70      0,5       0,1             24      0,1       0,0             Lip
  C01      26      0,2       0,1             6       0,0       0,0             Base of Tongue
  C02      348     2,5       0,7             184     1,1       0,3             Other and unspecified parts of tongue
  C03      75      0,5       0,1             29      0,2       0,1             Gum
  C04      60      0,4       0,1             16      0,1       0,0             Floor of mouth
  C05      57      0,4       0,1             38      0,2       0,1             Palate
  C06      472     3,4       0,9             161     1,0       0,3             Other and unspecified parts of mouth
  C07      92      0,7       0,2             53      0,3       0,1             Parotid gland
  C08      60      0,4       0,1             48      0,3       0,1             Other and unspecified major salivary gland
  C09      93      0,7       0,2             36      0,2       0,1             Tonsil
  C10      90      0,7       0,2             34      0,2       0,1             Oropharynx
  C11      173     1,3       0,3             93      0,6       0,2             Nasopharynx
  C12      259     1,9       0,5             39      0,2       0,1             Pyriform sinus
  C13      44      0,3       0,1             11      0,1       0,0             Hypopharynx
  C14      54      0,4       0,1             16      0,1       0,0             Other and ill-defined sites in lip oral cavity and mouth
  C15      362     2,6       0,7             233     1,5       0,4             Esophagus
  C16      1047    7,6       2               640     4,0       1,2             Stomach
  C17      53      0,4       0,1             44      0,3       0,1             Small intestine
  C18      347     2,5       0,7             277     1,7       0,5             Colon
  C19      21      0,2       0               13      0,1       0,0             Rectosegmoidjucnction
  C20      396     2,9       0,8             338     2,1       0,6             Rectum
  C21      40      0,3       0,1             27      0,2       0,0             Anus and anal canal
  C22      367     2,7       0,7             283     1,8       0,5             Liver
  C23      292     2,1       0,6             577     3,6       1,1             Gall bladder
  C24      66      0,5       0,1             73      0,5       0,1             Other and unspecified billary tract
  C25      158     1,1       0,3             129     0,8       0,2             Pancreas
  C26      15      0,1       0               6       0,0       0,0             Ill defined digestive organs
  C30      85      0,6       0,2             75      0,5       0,1             Nasal cavity and middle ear
  C31      74      0,5       0,1             73      0,5       0,1             Accessory sinus
  C32      741     5,4       1,4             243     1,5       0,4             Larynx
  C33      5       0         0               1       0,0       0,0             Trachea
  C34      2414    17,5      4,6             1634    10,2      3,0             Bronchus and lung
  C37      29      0,2       0,1             12      0,1       0,0             Thymus
  C38      34      0,2       0,1             20      0,1       0,0             Heart, mediastinum and pleura
  C39      2       0         0               2       0,0       0,0             Ill defined respiratory system
  C40      167     1,2       0,3             107     0,7       0,2             Bones joint and articular cartilage
  C41      173     1,3       0,3             133     0,8       0,2             Other and unspecified bones joints and articular cartilage
  C42      0       0         0               2       0,0       0,0             Spleen
  C43      94      0,7       0,2             71      0,4       0,1             Skin melanoma
  C44      113     0,8       0,2             107     0,7       0,2             Skin other
  C47      7       0,1       0               13      0,1       0,0             Perepheral nerves and autonomic nervous system
  C48      36      0,3       0,1             21      0,1       0,0             Peritoneum and retroperitoneum
  C49      241     1,7       0,5             188     1,2       0,3             Connective subcutaneous and other soft tissue
  C50      71      0,5       0,1             2505    15,6      4,6             Breast
  C51      0       0         0               107     0,7       0,2             Vulva
  C52      0       0         0               98      0,6       0,2             Vagina
  C53      0       0         0               3033    18,9      5,5             Cervix uteri
  C54      0       0         0               214     1,3       0,4             Endometrium
  C55      0       0         0               46      0,3       0,1             Uterus
  C56      0       0         0               1035    6,5       1,9             Ovary
  C57      0       0         0               118     0,7       0,2             Other and unspecified female genital organs
  C58      0       0         0               1       0,0       0,0             Placenta
  C60      230     1,7       0,4             0       0,0       0,0             Penis
  C61      248     1,8       0,5             0       0,0       0,0             Prostate gland
  C62      89      0,6       0,2             0       0,0       0,0             Testis
  C63      48      0,3       0,1             0       0,0       0,0             Other and unspecified male genital organs
  C64      182     1,3       0,4             113     0,7       0,2             Kidney
  C65      2       0         0               2       0,0       0,0             Renal Pelvis
  C66      2       0         0               0       0,0       0,0             Ureter
  C67      657     4,8       1,3             227     1,4       0,4             Bladder
  C68      12      0,1       0               10      0,1       0,0             Other unspecified urinary organs
  C69      93      0,7       0,2             100     0,6       0,2             Eye and adexa
  C70      24      0,2       0               39      0,2       0,1             Meninges
  C71      390     2,8       0,8             283     1,8       0,5             Brain
  C72      21      0,2       0               15      0,1       0,0             Spinal cord and other parts of CNS
  C73      154     1,1       0,3             487     3,0       0,9             Thyroid
  C74      6       0         0               5       0,0       0,0             Adrenal gland
  C75      13      0,1       0               10      0,1       0,0             Other endocrine and related
  C76      376     2,7       0,7             296     1,8       0,5             Other and ill-defined sites
  C77      61      0,4       0,1             38      0,2       0,1             Lymph nodes
  C80      227     1,6       0,4             189     1,2       0,3             Unknown Primary site
  C81      187     1,4       0,4             81      0,5       0,1             Hodgkin\'s disease
  C83      9       0,1       0               9       0,1       0,0             Diffuse non hodgkin lymphoma
  C85      470     3,4       0,9             276     1,7       0,5             Non hodgkin lymphoma
  C90      98      0,7       0,2             76      0,5       0,1             Multiple myeloma
  C91      323     2,3       0,6             172     1,1       0,3             Leukemia/lymphoid
  C92      350     2,5       0,7             237     1,5       0,4             Leukemia/myeloid
  C94      0       0         0               0       0,0       0,0             Other leukemia
  C95      94      0,7       0,2             61      0,4       0,1             Leukemia unspecified
  TOTAL    13789   100       26,5            16013   100,0     29,2            
  -------- ------- --------- --------------- ------- --------- --------------- ------------------------------------------------------------

[^1]: Author's Contribution: KKP has done conceptual design, searched the literature, drafted the manuscript, and revised it. The final review was done by KKP, ZH, PRN, RS, and JKP. .

[^2]: Conflict of interest: The authors hereby announce that they have no conflict of interest arising from the study.

[^3]: Source of Support: Nil
